Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J van der Hoeven

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1990
Endocrine tumorsJ J van der Hoeven, J Wagstaff
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1987
Endocrine tumorsJ J van der Hoeven, P S Schein
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1988
Endocrine tumorsJ J van der Hoeven, H M Pinedo
Cancer Chemotherapy and Pharmacology|January 1, 1987
Potentiation of doxorubicin cytotoxicity by the calcium antagonist bepridil in anthracycline-resistant and -sensitive cell lines. A comparison with verapamilG J Schuurhuis, H J Broxterman, J J van der Hoeven, et al.
Anti-Cancer Drugs|August 1, 1995
Spontaneous fracture of implanted central venous catheters in cancer patients: report of two cases and retrospective analysis of the 'pinch-off sign' as a risk factorC J Punt, S Strijk, J J van der Hoeven, et al.
Journal of the National Cancer Institute|November 8, 2001
Re: Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative managementH Torrenga, J Licht, J J van der Hoeven, et al.
Cancer Letters|April 1, 1987
Daunomycin accumulation in resistant tumor cells as a screening model for resistance modifying drugs: role of protein bindingH J Broxterman, C M Kuiper, G J Schuurhuis, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 19, 2000
[Added value of positron emission tomography with fluoro-18-deoxyglucose as the tracer (FDG-PET) in clinical problem cases in oncology]E F Comans, O S Hoekstra, K Hoekman, et al.
The New England Journal of Medicine|March 10, 1988
Swelling of metastatic tumors with high-dose interleukin therapyS H Goey, H J Voerman, R J Strack van Schijndel, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
Qualitative and quantitative kinetics of submucosally administered antibody fragments in patients with rectal carcinoma: the detection of lymph node metastasis in relation to local tracer diffusionJ C Roos, E J Derksen, A van Lingen, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1990
Endocrine tumorsJ J van der Hoeven, J Wagstaff
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1987
Endocrine tumorsJ J van der Hoeven, P S Schein
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1988
Endocrine tumorsJ J van der Hoeven, H M Pinedo
Cancer Chemotherapy and Pharmacology|January 1, 1987
Potentiation of doxorubicin cytotoxicity by the calcium antagonist bepridil in anthracycline-resistant and -sensitive cell lines. A comparison with verapamilG J Schuurhuis, H J Broxterman, J J van der Hoeven, et al.
Anti-Cancer Drugs|August 1, 1995
Spontaneous fracture of implanted central venous catheters in cancer patients: report of two cases and retrospective analysis of the 'pinch-off sign' as a risk factorC J Punt, S Strijk, J J van der Hoeven, et al.
Journal of the National Cancer Institute|November 8, 2001
Re: Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative managementH Torrenga, J Licht, J J van der Hoeven, et al.
Cancer Letters|April 1, 1987
Daunomycin accumulation in resistant tumor cells as a screening model for resistance modifying drugs: role of protein bindingH J Broxterman, C M Kuiper, G J Schuurhuis, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 19, 2000
[Added value of positron emission tomography with fluoro-18-deoxyglucose as the tracer (FDG-PET) in clinical problem cases in oncology]E F Comans, O S Hoekstra, K Hoekman, et al.
The New England Journal of Medicine|March 10, 1988
Swelling of metastatic tumors with high-dose interleukin therapyS H Goey, H J Voerman, R J Strack van Schijndel, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
Qualitative and quantitative kinetics of submucosally administered antibody fragments in patients with rectal carcinoma: the detection of lymph node metastasis in relation to local tracer diffusionJ C Roos, E J Derksen, A van Lingen, et al.
Pageof 2